Rare diseases
Investigational molecules
Locations
Husova 357/10, Liberec I-Stare Mesto, 460 01 Liberec (Neclenene Mesto), Czechia
Krajska nemocnice Liberec a.s. in Liberec (Neclenene Mesto), Czechia specialises in clinical trials of conditions such as Acute myocardial infarction, Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, Chronic obstructive pulmonary disease, and other specialisations. This site conducts important research.
More sites in Liberec (Neclenene Mesto)Czechia
Clinical trials currently enrolling participants at this site.
Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaStudy on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)
CzechiaStudy on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa
CzechiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
CzechiaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
CzechiaStudy on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4
CzechiaStudy on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain
CzechiaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
CzechiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
CzechiaA study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease
CzechiaA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
CzechiaStudy of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups
CzechiaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
